5[5]Uysal KT,Wlesbrock SM,Marino MW,et al .Protection from obesity-induced insulin resistance in mice lacking TNF-2 function.Nature,1997,389:610-614.
6[10]Vamecq J,Latruffe N.Medical significance of peroxisome proliferator-activated receptors. Lancet ,1999,354:141-148.
7[11]Yanauchi T,Kamon J,Waki H,et al .The common PPAR gamma Pro12Ala polymorphism is saaociated with decreased risk of type 2 diabetes.Nat Genet ,2000,26:76-80.
8[12]Yamauch:T,Kamon J,Waki H,et al.The fat-derived homone adiponectin reverse inswlin resistance associated with blth lipoatrophy and obesity.Nat Med ,2001,7:941-946.
9[13]Rieusset J,Chambrier C,BouzaKri K,et al. The expression of the p85 alpha subunit of phosphatidylinositol 3-Kinase is induced by activation of the peroxisome proliferator-activated rectptor gamma in human adipocytes.Diabetdogia,2001,44:544-554.
10[14]Chiang S H ,Baumann CA,Kanzaky M,et al.Insulin-stimulated GLUT4 translocation reguires the CAP-dependent activation of TC 10.Nature,2001,410:944-948.
3Valavanidis A, -1achogianni T, Fiotakis C. 8 - hydroxy - 2' - deoxyguanosine (8 - OHdG) : A critical biomarker of oxi- dative stress and carcinogenesis [ J ]. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev ,2009,27 (2) : 120 - 139.
5Madjid M,WillersonJT.Inflammatory markers in coronary heart disease[J].Br Med Bull, 2011,100( 1 ) : 23-38.
6Szwed H.Clinical benefits of trimetazidine in patients with recurrent angina [J]. Coron Artery Dis, 2004,15 (Supp 11 ) : S17-S21.
7Nezami N, Safa J,Salari B,et al.Effect of lovastatin thera- py and withdrawal on serum uric acid level in people with type 2 diabetic nephropathy[J].Nucleosides Nucleotides Nu- cleic Acids,2012,31(4) :353-363.
8Kim H J, Park KS, Lee SK,et al.Effects of pinitol on glycemic control,insulin resistance and adipocytokine levels in patients with type 2 diabetes mellitus[J].Ann Nutr Metab,2012,60 (1):1-5.
9Den Engelsen C, Koekkoek PS, Gorter K J, et al.High-sen- sitivity C-reactive protein to detect metabolic syndrome in a centrally obese population:a cross-sectional analysis[J]. Cardiovasc Diabetol, 2012, 11 (1) : 25.
10van der Velde M, Bello AK, Brantsma AH,et al.Do albu- minuria and hs-CRP add to the international Diabetes Federation definition of the metabolic syndrome in pre- dicting outcome?[J].Nephrol Dial Transplant,2012,27(6) : 2275-2283.
